Marianne de Backer, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), bought 4,000 shares at $54.95 ($134K) on 2020-01-13, disclosed to the SEC on 2020-06-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.95 | 500 | $27K | 20.5% |
| 2 | $35.07 | 500 | $18K | 13.1% |
| 3 | $34.39 | 500 | $17K | 12.8% |
| 4 | $28.60 | 500 | $14K | 10.7% |
| 5 | $24.80 | 500 | $12K | 9.2% |
| 6 | $23.94 | 500 |
| $12K |
| 8.9% |
| 7 | $35.40 | 500 | $18K | 13.2% |
| 8 | $31.33 | 500 | $16K | 11.7% |
| Total | $33.56 avg | 4,000 | $134K | 100% |
| Filing → |
| VIR | SELL | 2026-02-24 | $284K | — | Filing → |
| VIR | SELL | 2025-04-04 | $949K | — | Filing → |
| VIR | SELL | 2025-02-25 | $305K | — | Filing → |